Literature DB >> 32074581

Two Forms of Monomorphic Ventricular Tachycardia in a Patient with Brugada Syndrome.

Shota Kakehashi1, Tsukasa Kamakura1, Takeshi Aiba1, Kengo Kusano1.   

Abstract

We herein report a 47-year-old man with relapsing polychondritis who developed monomorphic ventricular tachycardia (VT). His electrocardiogram in sinus rhythm showed a coved-type pattern, and there was no evidence of structural cardiac disease; therefore, he was diagnosed with Brugada syndrome. An electrophysiological study revealed a prolonged His-ventricular interval at the baseline. Two forms of VT were induced, which were shown to be bundle branch reentrant VT. A diagnosis of Brugada syndrome should not be ruled out in patients with monomorphic VTs, especially those with conduction abnormalities.

Entities:  

Keywords:  Brugada syndrome; bundle branch reentrant ventricular tachycardia; ventricular tachycardia

Year:  2020        PMID: 32074581      PMCID: PMC7303447          DOI: 10.2169/internalmedicine.4299-19

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Brugada syndrome (BrS) is an arrhythmogenic disease that causes sudden cardiac death mainly due to ventricular fibrillation (VF) or polymorphic ventricular tachycardia (VT). However, rare cases of monomorphic VT arising from a focal origin, such as the outflow tract, or due to re-entry involving the conduction system have also been reported (1, 2). Thus far, there have been no case reports of patients with BrS combined with multiple forms of monomorphic VT. We herein report a patient with BrS who had two forms of monomorphic VT.

Case Report

A 47-year-old man with a history of relapsing polychondritis presented to our hospital with an episode of wide QRS tachycardia (195 beats/min) with a right bundle branch block (RBBB) pattern treated by cardioversion (Fig. 1A). No cardiac abnormality was observed on transthoracic echocardiography. Cardiac magnetic resonance imaging showed slight dilatation of the right ventricle (RV) (ratio of RV end-diastolic volume to body surface area: 106.8 mL/m2); however, there was no RV wall motion abnormality, sign of fatty infiltration, or late gadolinium enhancement indicative of arrhythmogenic right ventricular cardiomyopathy (Fig. 1B). The histological findings on a myocardial biopsy of the right ventricle showed mild hypertrophy of myocytes and mild interstitial and perivascular fibrosis. However, there were no fibrofatty replacement. His baseline electrocardiogram (ECG) in high intercostal spaces showed a spontaneous type 1 pattern associated with QRS fragmentation; therefore, he was diagnosed with BrS (Fig. 1C).
Figure 1.

(A) Twelve-lead ECG during a spontaneous episode of VT. (B) Delayed enhancement cardiac magnetic resonance with a coronal view showed no late gadolinium enhancement. RV: right ventricle, LV: left ventricle. (C) The baseline ECG of this 47-year-old man. Type 1 ECG patterns were observed in leads V1 and V2 in the 2nd intercostal space.

(A) Twelve-lead ECG during a spontaneous episode of VT. (B) Delayed enhancement cardiac magnetic resonance with a coronal view showed no late gadolinium enhancement. RV: right ventricle, LV: left ventricle. (C) The baseline ECG of this 47-year-old man. Type 1 ECG patterns were observed in leads V1 and V2 in the 2nd intercostal space. His baseline PQ and QRS intervals were slightly prolonged (217 and 137 ms, respectively). Genetic screening revealed that he carried an SCN5A variant (E1548K). His cousin died suddenly at 25 years old during sleep. He underwent an electrophysiological study, revealing a prolonged His-ventricular interval of 80 ms at the baseline (Fig. 2A). Initially, VF was repeatedly induced by double extrastimuli from the RV apex. After the injection of a low-dose sodium channel blocker (12.5 mg pilsicainide), two different sustained VTs were induced (Fig. 2B, C): one was almost identical to the clinical wide QRS tachycardia with an RBBB pattern (Fig. 2B), and the other VT was a left bundle branch block (LBBB) pattern with left-axis deviation (Fig. 2C). The tachycardia with an RBBB pattern was diagnosed as bundle branch reentrant VT (BBRVT) based on the following findings: (1) atrio-ventricular dissociation, (2) His bundle electrograms (H) preceded every ventricular electrogram (V) with the H-V interval greater than that recorded during sinus rhythm (Fig. 2D), and (3) spontaneous changes in H-H intervals preceded similar changes in V-V intervals (Fig. 2D). We were unable to perform a detailed electrophysiological study of VT with the LBBB pattern because only VT with the RBBB pattern was subsequently induced.
Figure 2.

(A) Intracardiac recordings from the His bundle during an electrophysiological study. The His-ventricular interval was 80 ms during sinus rhythm. (B) A 12-lead ECG of induced tachycardia during an electrophysiological study with a right bundle branch block pattern. (C) A 12-lead ECG of induced tachycardia during an electrophysiological study with a left bundle branch block pattern. (D) Intracardiac recordings during ventricular tachycardia with the right bundle branch block pattern. An ablation catheter was placed at the His potential recording site at the base of the left ventricle. The His-ventricular interval was greater than that recorded during sinus rhythm (90 ms). Spontaneous changes in the His-His intervals preceded similar changes in the ventricular-ventricular intervals. V: ventricle

(A) Intracardiac recordings from the His bundle during an electrophysiological study. The His-ventricular interval was 80 ms during sinus rhythm. (B) A 12-lead ECG of induced tachycardia during an electrophysiological study with a right bundle branch block pattern. (C) A 12-lead ECG of induced tachycardia during an electrophysiological study with a left bundle branch block pattern. (D) Intracardiac recordings during ventricular tachycardia with the right bundle branch block pattern. An ablation catheter was placed at the His potential recording site at the base of the left ventricle. The His-ventricular interval was greater than that recorded during sinus rhythm (90 ms). Spontaneous changes in the His-His intervals preceded similar changes in the ventricular-ventricular intervals. V: ventricle Proximal right bundle branch ablation during VT resulted in VT termination and rendered all VTs non-inducible. An ECG after ablation showed a coved-type pattern associated with the RBBB pattern (Fig. 3). He underwent transvenous implantable cardioverter-defibrillator implantation. He continued taking prednisolone for relapsing polychondritis. He remained free from monomorphic VT and VF without taking antiarrhythmic drugs during a follow-up period of 24 months. Transthoracic echocardiography 24 months after ablation showed no cardiac abnormality.
Figure 3.

An ECG after ablation showed a coved-type pattern associated with right bundle branch block in lead V2 in the standard position and in leads V1-3 in the second and third intercostal spaces.

An ECG after ablation showed a coved-type pattern associated with right bundle branch block in lead V2 in the standard position and in leads V1-3 in the second and third intercostal spaces.

Discussion

To our knowledge, this is the first reported case of a BrS patient with two forms of VT. The diagnosis of very-early-stage arrhythmogenic right ventricular cardiomyopathy cannot be excluded; however, he showed no cardiac abnormalities indicative of the presence of arrhythmogenic right ventricular cardiomyopathy at diagnosis and during a 2-year follow-up period. In this case, clinical VT with an RBBB morphology was diagnosed as BBRVT, possibly with antegrade conduction down the left bundle and retrograde conduction along the right bundle. Although a detailed electrophysiological study was not performed during another VT with LBBB pattern, this may have represented BBRVT with an opposite circuit, i.e. antegrade conduction down the right bundle and retrograde conduction along the left bundle, because ablation of the proximal right bundle branch rendered all VTs non-inducible. BBRVT is characterized by macro re-entry within an abnormal His-Purkinje system. Although classically associated with structural heart disease such as dilated cardiomyopathy, BBRVT can occur in the absence of such disease as well. Recently, idiopathic BBRVT was reported in patients with mutations within genes implicated in conduction disease, such as SCN5A and LMNA (3). SCN5A mutations have been linked to BrS. It is known that BrS patients with SCN5A mutation have a longer PQ interval and QRS duration than those without (4). We did not perform a functional analysis of the SCN5A variant identified in this case (E1548K); however, in silico prediction of the functional consequences of missense mutations using Polymorphism Phenotyping v2 predicted this variant to be possibly damaging, with a score of 0.902. The prolonged PQ and His-ventricular intervals as well as the Brugada-pattern ECG in this patient may have been due to the SCN5A variant. Relapsing polychondritis is another possible cause of the prolonged PQ and His-ventricular interval in this patient. Although relapsing polychondritis is a relatively rare multisystemic disease with recurrent inflammation, cardiac involvement is one of the major causes of mortality in this disease. A multicenter study of 62 polychondritis patients reported cardiac abnormalities in 22% of the patients (5). Of note, two patients had atrioventricular block, which suggests that relapsing polychondritis can cause cardiac conduction disturbance. Thus far, there have been no reports of relapsing polychondritis associated with BrS. The association between relapsing polychondritis and BrS may be fortuitous in this case. Further studies are warranted to investigate the link between them. In conclusion, we encountered a case of BrS associated with BBRVT. A diagnosis of BrS should not be ruled out in patients with monomorphic VTs, especially those with conduction abnormalities.

The authors state that they have no Conflict of Interest (COI).

Financial Support

This work was supported by the Japan Society for the Promotion of Science (JSPS) through a Grant-in-Aid for Scientific Research (KAKENHI Grant Number JP17K09545).
  5 in total

1.  Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients.

Authors:  M Zeuner; R H Straub; G Rauh; E D Albert; J Schölmerich; B Lang
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

2.  Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.

Authors:  Kenichiro Yamagata; Minoru Horie; Takeshi Aiba; Satoshi Ogawa; Yoshifusa Aizawa; Tohru Ohe; Masakazu Yamagishi; Naomasa Makita; Harumizu Sakurada; Toshihiro Tanaka; Akihiko Shimizu; Nobuhisa Hagiwara; Ryoji Kishi; Yukiko Nakano; Masahiko Takagi; Takeru Makiyama; Seiko Ohno; Keiichi Fukuda; Hiroshi Watanabe; Hiroshi Morita; Kenshi Hayashi; Kengo Kusano; Shiro Kamakura; Satoshi Yasuda; Hisao Ogawa; Yoshihiro Miyamoto; Jamie D Kapplinger; Michael J Ackerman; Wataru Shimizu
Journal:  Circulation       Date:  2017-03-24       Impact factor: 29.690

3.  Bundle Branch Re-Entrant Ventricular Tachycardia: Novel Genetic Mechanisms in a Life-Threatening Arrhythmia.

Authors:  Jason D Roberts; Michael H Gollob; Charlie Young; Sean P Connors; Chris Gray; Stephen B Wilton; Martin S Green; Dennis W Zhu; Kathleen A Hodgkinson; Annie Poon; Qiuju Li; Nathan Orr; Anthony S Tang; George J Klein; Julianne Wojciak; Joan Campagna; Jeffrey E Olgin; Nitish Badhwar; Vasanth Vedantham; Gregory M Marcus; Pui-Yan Kwok; Rahul C Deo; Melvin M Scheinman
Journal:  JACC Clin Electrophysiol       Date:  2016-12-21

4.  Bundle branch reentrant ventricular tachycardia in a patient with the Brugada electrocardiographic pattern.

Authors:  Alexander Mazur; Zaza Iakobishvili; Jairo Kusniec; Boris Strasberg
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

5.  Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.

Authors:  Moisés Rodríguez-Mañero; Frédéric Sacher; Carlo de Asmundis; Philippe Maury; Pier D Lambiase; Andrea Sarkozy; Vincent Probst; Estelle Gandjbakhch; Jesús Castro-Hevia; Johan Saenen; Kengo Fukushima Kusano; Anne Rollin; Elena Arbelo; Miguel Valderrábano; Miguel A Arias; Ignacio Mosquera-Pérez; Richard Schilling; Gian-Battista Chierchia; Ignacio García-Bolao; Javier García-Seara; Jaime Hernandez-Ojeda; Tsukasa Kamakura; Luis Martínez-Sande; José Ramón González-Juanatey; Michel Haïssaguerre; Josep Brugada; Pedro Brugada
Journal:  Heart Rhythm       Date:  2015-10-29       Impact factor: 6.779

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.